APA (7th ed.) Citation

Boshuisen, M., & den Boer, J. (2000). Zolmitriptan (a 5-HT[sub 1B/1D] receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder. Psychopharmacology, 152(1), 74. https://doi.org/10.1007/s002130000529

Chicago Style (17th ed.) Citation

Boshuisen, M.L, and J.A den Boer. "Zolmitriptan (a 5-HT[sub 1B/1D] Receptor Agonist with Central Action) Does Not Increase Symptoms in Obsessive Compulsive Disorder." Psychopharmacology 152, no. 1 (2000): 74. https://doi.org/10.1007/s002130000529.

MLA (9th ed.) Citation

Boshuisen, M.L, and J.A den Boer. "Zolmitriptan (a 5-HT[sub 1B/1D] Receptor Agonist with Central Action) Does Not Increase Symptoms in Obsessive Compulsive Disorder." Psychopharmacology, vol. 152, no. 1, 2000, p. 74, https://doi.org/10.1007/s002130000529.